Insider Trading activities at Pacira Biosciences, Inc. (PCRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pacira Biosciences, Inc. (PCRX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pacira Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1396814.

Total stock buying since 2015: $1,511,746.
Total stock sales since 2015: $134,046,095.
Total stock option exercises since 2015: $25,248,807.


 1   2 
29 insiders reported insider trading activities at Pacira Biosciences, Inc. (PCRX):
Insider trading activities of Stack David M
Insider trading activities of Brege Laura
Insider trading activities of Reinhardt Max
Insider trading activities of Braunstein Scott
Insider trading activities of Kronenfeld Mark A.
Insider trading activities of Molloy Anthony
Insider trading activities of Longenecker John P Phd
Insider trading activities of Hastings Paul J
Insider trading activities of Winston Roy
Insider trading activities of Slonin Jonathan
Insider trading activities of Weiland Robert J.
Insider trading activities of Williams Kristen Marie
Insider trading activities of Reinhart Charles A. Iii
Insider trading activities of Markvicka Taunia
Insider trading activities of Pace Gary W
Insider trading activities of Bigal Marcelo
Insider trading activities of Jones James B
Insider trading activities of Riker Lauren Bullaro
Insider trading activities of Gaugler Daryl
Insider trading activities of Scranton Richard
Insider trading activities of Manning Donald C.
Insider trading activities of Froimson Mark
Insider trading activities of Wicki Andreas
Insider trading activities of Yang Michael J.
Insider trading activities of Laranjeira Charles Anthony
Insider trading activities of Lee Frank D.
Insider trading activities of Ellis Ronald J. Jr.
Insider trading activities of Scibetta James S
Insider trading activities of Mcloughlin Dennis

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Pacira Biosciences, Inc. (PCRX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 20,833 $539,598 0 $0
2024 17,576 $215,684 142,418 $4,293,651 0 $0
2023 0 $0 75,177 $2,936,447 23,500 $712,900
2022 0 $0 227,928 $15,306,874 252,372 $6,507,813
2021 0 $0 400,927 $28,062,960 167,093 $3,407,228
2020 2,500 $91,250 691,456 $39,746,803 478,835 $10,972,788
2019 1,700 $66,181 180,507 $7,746,578 158,807 $1,273,560
2018 9,500 $457,581 284,591 $12,905,232 126,976 $559,010
2017 1,100 $45,316 190,915 $7,882,924 173,811 $872,627
2016 3,800 $235,054 122,574 $6,058,768 148,000 $484,035
2015 6,000 $400,680 104,000 $8,566,260 112,349 $458,846

Table 2. Monthly summary of insider trading at Pacira Biosciences, Inc. (PCRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 0 $0 19,954 $523,425 0 $0
2025-01 0 $0 879 $16,173 0 $0
2024-12 0 $0 500 $9,880 0 $0
2024-09 0 $0 500 $6,430 0 $0
2024-08 17,576 $215,684 945 $18,947 0 $0
2024-07 0 $0 2,836 $80,117 0 $0
2024-06 0 $0 18,314 $522,051 0 $0
2024-03 0 $0 119,323 $3,656,226 0 $0
2023-08 0 $0 509 $17,751 0 $0
2023-07 0 $0 643 $25,019 0 $0
2023-06 0 $0 51,806 $1,981,368 0 $0
2023-05 0 $0 14,515 $600,176 16,500 $503,600
2023-04 0 $0 7,000 $285,040 7,000 $209,300
2023-01 0 $0 704 $27,093 0 $0
2022-10 0 $0 1,380 $80,040 0 $0
2022-08 0 $0 784 $43,668 0 $0
2022-07 0 $0 1,457 $83,195 0 $0
2022-06 0 $0 77,781 $4,759,449 12,250 $444,943
2022-05 0 $0 1,000 $59,370 2,000 $104,740
2022-04 0 $0 60,350 $4,505,637 95,000 $3,254,835
2022-03 0 $0 24,912 $1,786,660 54,412 $823,258
2022-02 0 $0 31,701 $2,115,279 31,701 $432,973
2022-01 0 $0 28,563 $1,873,576 57,009 $1,447,064
2021-11 0 $0 0 $0 32,500 $974,400

Table 3. Detailed insider trading at Pacira Biosciences, Inc. (PCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-04 Riker Lauren (Senior Vice President, Finance) Sale 5,578 26.21 146,199
2025-06-04 Williams Kristen (Chief Administrative Officer) Sale 14,376 26.24 377,226
2025-01-06 Slonin Jonathan (Chief Medical Officer) Sale 879 18.40 16,173
2024-12-13 Gaugler Daryl (Chief Operating Officer) Sale 500 19.76 9,880
2024-09-13 Gaugler Daryl (Chief Operating Officer) Sale 500 12.86 6,430
2024-08-16 Bigal Marcelo (Director) Buy 1,512 13.25 20,034
2024-08-16 Brege Laura (Director) Buy 1,000 12.81 12,810
2024-08-14 Yang Michael J. (Director) Buy 2,000 12.90 25,800
2024-08-12 Bigal Marcelo (Director) Buy 3,400 12.01 40,834
2024-08-12 Lee Frank D. (Chief Executive Officer) Buy 8,264 12.10 99,994
2024-08-12 Froimson Mark (Director) Buy 1,400 11.58 16,212
2024-08-02 Slonin Jonathan (Chief Medical Officer) Sale 945 20.05 18,947
2024-07-02 Slonin Jonathan (Chief Medical Officer) Sale 2,836 28.25 80,117
2024-06-13 Gaugler Daryl (Chief Operating Officer) Sale 1,000 28.38 28,380
2024-06-13 Hastings Paul J (Director) Sale 880 28.38 24,974
2024-06-13 Williams Kristen (Chief Administrative Officer) Sale 7,452 28.38 211,487
2024-06-12 Riker Lauren (Senior Vice President, Finance) Sale 3,970 28.72 114,018
2024-06-11 Slonin Jonathan (Chief Medical Officer) Sale 5,012 28.57 143,192
2024-03-08 Pace Gary W (Director) Sale 90,000 30.60 2,754,000
2024-03-07 Pace Gary W (Director) Sale 28,257 30.81 870,598
2024-03-06 Pace Gary W (Director) Sale 1,066 29.67 31,628
2023-08-02 Winston Roy (Chief Medical Officer) Sale 509 34.88 17,751
2023-07-05 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 643 38.91 25,019
2023-06-14 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 6,366 38.33 244,027
2023-06-14 Williams Kristen Marie (Chief Administrative Officer) Sale 6,467 37.03 239,473
2023-06-07 Gaugler Daryl (Chief Operating Officer) Sale 1,047 37.87 39,644
2023-06-07 Slonin Jonathan (Chief Clinical Officer) Sale 490 37.87 18,553
2023-06-07 Ellis Ronald J. Jr. (Chief Strategy Officer) Sale 1,162 37.87 43,999
2023-06-07 Reinhardt Max (President, Rest of World) Sale 1,099 37.87 41,613
2023-06-07 Mcloughlin Dennis (Chief Customer Officer) Sale 1,057 37.87 40,023
2023-06-07 Winston Roy (Chief Medical Officer) Sale 1,857 37.87 70,315
2023-06-07 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 616 37.87 23,324
2023-06-07 Reinhart Charles A. Iii (Chief Financial Officer) Sale 1,371 37.87 51,912
2023-06-07 Williams Kristen Marie (Chief Administrative Officer) Sale 1,357 37.87 51,382
2023-06-07 Stack David M (CEO and Chairman) Sale 5,326 37.87 201,668
2023-06-06 Gaugler Daryl (Chief Operating Officer) Sale 1,005 38.99 39,185
2023-06-06 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 4,521 38.55 174,284
2023-06-06 Slonin Jonathan (Chief Clinical Officer) Sale 471 38.99 18,364
2023-06-06 Ellis Ronald J. Jr. (Chief Strategy Officer) Sale 1,114 38.99 43,435
2023-06-06 Reinhardt Max (President, Rest of World) Sale 1,054 38.99 41,096
2023-06-06 Mcloughlin Dennis (Chief Customer Officer) Sale 1,014 38.99 39,536
2023-06-06 Winston Roy (Chief Medical Officer) Sale 1,779 38.99 69,364
2023-06-06 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 591 38.99 23,043
2023-06-06 Reinhart Charles A. Iii (Chief Financial Officer) Sale 1,236 38.99 48,192
2023-06-06 Williams Kristen Marie (Chief Administrative Officer) Sale 1,301 38.99 50,727
2023-06-06 Stack David M (CEO and Chairman) Sale 5,058 38.99 197,216
2023-06-05 Gaugler Daryl (Chief Operating Officer) Sale 1,000 38.74 38,740
2023-06-05 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 2,267 38.28 86,773
2023-06-05 Brege Laura (Director) Sale 600 38.74 23,244
2023-06-05 Hastings Paul J (Director) Sale 580 38.34 22,236
2023-05-31 Gaugler Daryl (Chief Operating Officer) Sale 2,500 39.08 97,700
2023-05-31 Gaugler Daryl (Chief Operating Officer) Option Ex 2,500 34.00 85,000
2023-05-15 Hastings Paul J (Director) Sale 7,000 41.85 292,950
2023-05-15 Hastings Paul J (Director) Option Ex 7,000 29.90 209,300
2023-05-11 Pace Gary W (Director) Sale 5,015 41.78 209,526
2023-05-11 Pace Gary W (Director) Option Ex 7,000 29.90 209,300
2023-04-03 Brege Laura (Director) Sale 7,000 40.72 285,040
2023-04-03 Brege Laura (Director) Option Ex 7,000 29.90 209,300
2023-01-05 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 546 38.31 20,917
2023-01-04 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 158 39.09 6,176
2022-10-07 Reinhardt Max (President, Rest of World) Sale 1,380 58.00 80,040
2022-08-03 Slonin Jonathan (Chief Clinical Officer) Sale 308 55.70 17,155
2022-08-03 Winston Roy (Chief Medical Officer) Sale 476 55.70 26,513
2022-07-11 Hastings Paul J (Director) Sale 533 56.95 30,354
2022-07-05 Slonin Jonathan (Chief Clinical Officer) Sale 924 57.19 52,841
2022-06-14 Laranjeira Charles Anthony (Chief Technical Officer) Option Ex 6,000 38.35 230,100
2022-06-08 Laranjeira Charles Anthony (Chief Technical Officer) Sale 4,937 60.57 299,034
2022-06-08 Stack David M (CEO and Chairman) Sale 13,828 60.67 839,013
2022-06-07 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 2,570 59.89 153,917
2022-06-07 Reinhardt Max (President, Rest of World) Sale 2,433 62.00 150,846
2022-06-07 Williams Kristen Marie (Chief Administrative Officer) Sale 4,649 59.51 276,661
2022-06-06 Gaugler Daryl (Chief Operating Officer) Sale 1,106 61.37 67,879
2022-06-06 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 2,980 61.37 182,894
2022-06-06 Slonin Jonathan (Chief Clinical Officer) Sale 362 61.37 22,217
2022-06-06 Reinhardt Max (President, Rest of World) Sale 2,817 61.37 172,890
2022-06-06 Mcloughlin Dennis (Chief Customer Officer) Sale 2,140 61.37 131,340
2022-06-06 Winston Roy (Chief Medical Officer) Sale 17,546 61.96 1,087,185
2022-06-06 Winston Roy (Chief Medical Officer) Option Ex 6,250 34.38 214,843
2022-06-06 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 1,150 61.37 70,580
2022-06-06 Laranjeira Charles Anthony (Chief Technical Officer) Sale 2,813 61.37 172,645
2022-06-06 Reinhart Charles A. Iii (Chief Financial Officer) Sale 2,516 61.37 154,416
2022-06-06 Williams Kristen Marie (Chief Administrative Officer) Sale 3,969 61.37 243,593
2022-06-06 Stack David M (CEO and Chairman) Sale 11,965 61.37 734,339
2022-05-23 Slonin Jonathan (Chief Clinical Officer) Option Ex 2,000 52.37 104,740
2022-05-09 Froimson Mark (Director) Sale 1,000 59.37 59,370
2022-04-28 Stack David M (CEO and Chairman) Option Ex 22,500 10.81 243,225
2022-04-21 Reinhardt Max (President, Rest of World) Sale 9,824 73.25 719,647
2022-04-21 Reinhardt Max (President, Rest of World) Option Ex 12,500 42.54 531,750
2022-04-20 Reinhardt Max (President, Rest of World) Sale 9,764 73.99 722,438
2022-04-20 Reinhardt Max (President, Rest of World) Option Ex 12,500 42.54 531,750
2022-04-19 Reinhardt Max (President, Rest of World) Sale 9,321 72.25 673,442
2022-04-19 Reinhardt Max (President, Rest of World) Option Ex 12,500 42.54 531,750
2022-04-18 Reinhardt Max (President, Rest of World) Sale 8,941 73.55 657,610
2022-04-18 Reinhardt Max (President, Rest of World) Option Ex 12,500 42.54 531,750
2022-04-06 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 22,500 77.00 1,732,500
2022-04-06 Molloy Anthony (Chief Lgl & Compliance Officer) Option Ex 22,500 39.32 884,610
2022-03-31 Stack David M (CEO and Chairman) Option Ex 22,500 10.81 243,225
2022-03-21 Williams Kristen Marie (Chief Administrative Officer) Sale 7,253 72.67 527,075
2022-03-21 Williams Kristen Marie (Chief Administrative Officer) Option Ex 7,253 43.18 313,184
2022-03-10 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 9,300 71.55 665,368
2022-03-10 Riker Lauren Bullaro (Senior Vice President, Finance) Option Ex 9,300 10.81 100,533
2022-03-03 Longenecker John P Phd (Director) Sale 7,000 71.73 502,145
2022-03-03 Longenecker John P Phd (Director) Option Ex 7,000 10.81 75,670
2022-03-03 Pace Gary W (Director) Option Ex 7,000 10.81 75,670
2022-03-01 Pace Gary W (Director) Sale 1,359 67.75 92,072
2022-03-01 Pace Gary W (Director) Option Ex 1,359 11.02 14,976
2022-02-28 Pace Gary W (Director) Sale 28,641 66.83 1,914,078
2022-02-28 Pace Gary W (Director) Option Ex 28,641 11.02 315,623
2022-02-25 Williams Kristen Marie (Chief Administrative Officer) Sale 2,050 66.03 135,371
2022-02-25 Williams Kristen Marie (Chief Administrative Officer) Option Ex 2,050 38.35 78,617
2022-02-16 Williams Kristen Marie (Chief Administrative Officer) Sale 10 65.00 650
2022-02-16 Williams Kristen Marie (Chief Administrative Officer) Option Ex 10 38.35 383
2022-02-04 Williams Kristen Marie (Chief Administrative Officer) Sale 1,000 65.18 65,180
2022-02-04 Williams Kristen Marie (Chief Administrative Officer) Option Ex 1,000 38.35 38,350
2022-01-25 Stack David M (CEO and Chairman) Option Ex 13,670 10.81 147,772
2022-01-21 Williams Kristen Marie (Chief Administrative Officer) Sale 200 65.41 13,082
2022-01-21 Williams Kristen Marie (Chief Administrative Officer) Option Ex 200 38.35 7,670
2022-01-19 Williams Kristen Marie (Chief Administrative Officer) Sale 2,199 65.51 144,056
2022-01-19 Williams Kristen Marie (Chief Administrative Officer) Option Ex 2,199 38.35 84,331
2022-01-18 Molloy Anthony (Chief Lgl & Compliance Officer) Sale 224 63.55 14,235
2022-01-18 Riker Lauren Bullaro (Senior Vice President, Finance) Sale 2,500 64.97 162,430
2022-01-18 Riker Lauren Bullaro (Senior Vice President, Finance) Option Ex 2,500 10.81 27,025
2022-01-18 Williams Kristen Marie (Chief Administrative Officer) Sale 23,440 65.69 1,539,773
2022-01-18 Williams Kristen Marie (Chief Administrative Officer) Option Ex 23,440 43.44 1,018,116
2022-01-11 Stack David M (CEO and Chairman) Option Ex 15,000 10.81 162,150
2021-11-22 Laranjeira Charles Anthony (Chief Technical Officer) Option Ex 7,500 44.10 330,750
2021-11-16 Stack David M (CEO and Chairman) Option Ex 15,000 10.81 162,150
2021-11-04 Winston Roy (Chief Medical Officer) Option Ex 10,000 48.15 481,500
2021-07-29 Riker Lauren Bullaro (Vice President, Finance) Sale 90 60.81 5,472
2021-07-29 Riker Lauren Bullaro (Vice President, Finance) Option Ex 90 10.81 972
2021-07-28 Riker Lauren Bullaro (Vice President, Finance) Sale 2,410 60.85 146,648
2021-07-28 Riker Lauren Bullaro (Vice President, Finance) Option Ex 2,410 10.81 26,052
2021-07-02 Reinhardt Max (President, Rest of World) Sale 421 59.76 25,158
2021-06-11 Riker Lauren Bullaro (Vice President, Finance) Sale 2,003 59.85 119,879
2021-06-10 Williams Kristen Marie (Chief Administrative Officer) Sale 5,689 60.00 341,340
2021-06-04 Riker Lauren Bullaro (Vice President, Finance) Sale 1,047 61.04 63,905
2021-06-04 Williams Kristen Marie (Chief Administrative Officer) Sale 3,930 61.04 239,875
2021-06-02 Manning Donald C. (Chief Medical Officer) Sale 2,380 62.12 147,852
2021-05-12 Stack David M (CEO and Chairman) Sale 21,250 61.75 1,312,187
2021-05-12 Stack David M (CEO and Chairman) Option Ex 21,250 10.81 229,712
2021-05-11 Stack David M (CEO and Chairman) Sale 21,250 60.98 1,295,931
2021-05-11 Stack David M (CEO and Chairman) Option Ex 21,250 10.81 229,712
2021-04-13 Williams Kristen Marie (Chief Administrative Officer) Sale 21,823 67.25 1,467,705
2021-04-13 Williams Kristen Marie (Chief Administrative Officer) Option Ex 21,823 39.61 864,409
2021-03-31 Winston Roy (Chief Clinical Officer) Sale 22,224 71.19 1,582,126
2021-03-31 Winston Roy (Chief Clinical Officer) Option Ex 13,750 34.38 472,656
2021-03-17 Riker Lauren Bullaro (Vice President, Finance) Sale 2,000 70.01 140,020
2021-03-17 Riker Lauren Bullaro (Vice President, Finance) Option Ex 2,000 10.81 21,620
2021-03-15 Froimson Mark (Director) Sale 734 72.26 53,038
2021-03-15 Riker Lauren Bullaro (Vice President, Finance) Sale 1,520 73.28 111,385
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of PCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pacira Biosciences, Inc. (symbol PCRX, CIK number 1396814) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.